[HTML][HTML] Capsid inhibition with lenacapavir in multidrug-resistant HIV-1 infection
S Segal-Maurer, E DeJesus, HJ Stellbrink… - … England Journal of …, 2022 - Mass Medical Soc
Background Patients with multidrug-resistant human immunodeficiency virus type 1 (HIV-1)
infection have limited treatment options. Lenacapavir is a first-in-class capsid inhibitor that …
infection have limited treatment options. Lenacapavir is a first-in-class capsid inhibitor that …